Pavel Klein

Featured in: Favicon

nature.com Favicon

jamanetwork.com Favicon

thelancet.com Favicon

healio.com Favicon

neurology.org Favicon

neurologylive.com Favicon

Articles

Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medications

1 month ago | onlinelibrary.wiley.com | Michael Sperling |William Rosenfeld |JOhn Watson |John Watson |Pavel Klein

Seizure freedom has been a goal of epilepsy treatment for >25 years, but rates of seizure freedom have changed little during this time. Uncontrolled FBTCS are the greatest risk factor for SUDEP. Adjunctive cenobamate treatment is associated with rapid and sustained rates of freedom from FBTCS in drug-resistant focal epilepsy patients. Effective prescribing practices and clear communication can help patients attain seizure freedom and significantly reduce their risk of SUDEP.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →